These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 6451649

  • 21. Immunosuppression in vitro and in vivo by supernatants from murine lymphoma cell lines.
    Klajman A, Drucker I, Zan-Bar I, Mekori Y, Ben-Efraim S.
    Anticancer Res; 1992; 12(3):741-7. PubMed ID: 1535768
    [Abstract] [Full Text] [Related]

  • 22. Serum-mediated suppression of nonspecific B cell activation. II. Relative resistance of B cells from the NZB mouse strain to regulation by a natural inhibitor in normal mouse serum.
    Walker SM, Sturtevant JE, Weigle WO.
    J Immunol; 1981 Sep; 127(3):1204-7. PubMed ID: 6973581
    [Abstract] [Full Text] [Related]

  • 23. Permanent hapten-specific tolerance in B lymphocytes.
    Elson CJ, Taylor RB.
    Immunology; 1975 Mar; 28(3):543-52. PubMed ID: 1079199
    [Abstract] [Full Text] [Related]

  • 24. Cell-mediated immunity to Friend virus-induced leukemia. II. Characteristics of primary cell-mediated cytotoxic response.
    Ting CC, Rodgigues D, Bushar GS, Herberman RB.
    J Immunol; 1976 Jan; 116(1):236-43. PubMed ID: 54387
    [Abstract] [Full Text] [Related]

  • 25. Recognition of protozoan parasites by murine T lymphocytes. II. Role of the H-2 gene complex in interactions between antigen-presenting macrophages and Leishmania-immune T lymphocytes.
    Louis JA, Moedder E, MacDonald HR, Engers HD.
    J Immunol; 1981 May; 126(5):1661-6. PubMed ID: 6452473
    [Abstract] [Full Text] [Related]

  • 26. Suppressor cells in the spleen of tumor-allosensitized mice.
    Argyris BF.
    Cancer Res; 1977 Sep; 37(9):3390-9. PubMed ID: 141979
    [Abstract] [Full Text] [Related]

  • 27. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L, Reich S, Slavin S.
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
    [Abstract] [Full Text] [Related]

  • 28. Cell-mediated immunity in experimental murine dermatophytosis. I. Temporal aspects of T-suppressor activity caused by Trichophyton quinckeanum.
    Calderon RA, Hay RJ.
    Immunology; 1984 Nov; 53(3):457-64. PubMed ID: 6237986
    [Abstract] [Full Text] [Related]

  • 29. Physiology of Igd. II. Lack of humoral immune responsiveness in lymph nodes of mice treated with anti-IgD from birth.
    Baine Y, Chen YW, Jacobson EB, Pernis B, Siskind GW, Thorbecke GJ.
    Eur J Immunol; 1982 Oct; 12(10):882-6. PubMed ID: 6983443
    [Abstract] [Full Text] [Related]

  • 30. Comparison of antigen presentation by lymph node cells from protein and peptide-primed mice.
    Hoyne GF, Callow MG, Kuo MC, Thomas WR.
    Immunology; 1993 Jan; 78(1):58-64. PubMed ID: 8436404
    [Abstract] [Full Text] [Related]

  • 31. Differential function of dendritic cells isolated from blood and lymph nodes.
    Hill S, Coates JP, Kimber I, Knight SC.
    Immunology; 1994 Oct; 83(2):295-301. PubMed ID: 7835950
    [Abstract] [Full Text] [Related]

  • 32. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
    Patel M, Havas HF.
    Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
    [Abstract] [Full Text] [Related]

  • 33. Differences in the migration of B and T lymphocytes: organ-selective localization in vivo and the role of lymphocyte-endothelial cell recognition.
    Stevens SK, Weissman IL, Butcher EC.
    J Immunol; 1982 Feb; 128(2):844-51. PubMed ID: 6976385
    [Abstract] [Full Text] [Related]

  • 34. Immunosuppression associated with SJL/J murine lymphoma. I. Suppression of cell-mediated immune responses after tumor transplantation.
    Kumar RK, Lykke AW, Penny R.
    J Natl Cancer Inst; 1981 Dec; 67(6):1269-75. PubMed ID: 6458725
    [Abstract] [Full Text] [Related]

  • 35. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
    Saxon A, Portaro J.
    Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
    [Abstract] [Full Text] [Related]

  • 36. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P, Vourka-Karussis U, Weiss L, Slavin S.
    J Immunol; 1993 Nov 01; 151(9):4803-10. PubMed ID: 8409438
    [Abstract] [Full Text] [Related]

  • 37. Immunocompetence status as related to growth progression of mouse MOPC-315 plasmacytoma.
    Rashid G, Ophir R, Pecht M, Ben-Efraim S.
    In Vivo; 1989 Nov 01; 3(4):279-84. PubMed ID: 2535271
    [Abstract] [Full Text] [Related]

  • 38. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
    Friedman H, Kateley JR.
    Am J Clin Pathol; 1975 May 01; 63(5):735-47. PubMed ID: 1093386
    [Abstract] [Full Text] [Related]

  • 39. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS, Miller CH, Graham L, Parviz M, Zacur S, Patel B, Duong A, Bear HD.
    Int Immunol; 2004 Sep 01; 16(9):1283-94. PubMed ID: 15262898
    [Abstract] [Full Text] [Related]

  • 40. Lymphocyte function in experimental African trypanosomiasis. III. Loss of lymph node cell responsiveness.
    Wellhausen SR, Mansfield JM.
    J Immunol; 1980 Mar 01; 124(3):1183-6. PubMed ID: 6444647
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.